プレスリリース

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO--(BUSINESS WIRE)--Feb. 27, 2018-- Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Cowen and Company Annual Health Care Conference, Boston, MA on March 13, 2018 at 10:40 am Eastern Time.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

Source: Illumina, Inc.

Investors:
Jacquie Ross, CFA
858-882-2172
ir@illumina.com
or
Media:
Eric Endicott
858-882-6822
pr@illumina.com

最近の記事

ヒトゲノムの暗黒領域に潜む手がかりの探索
ヒトゲノムの暗黒領域に潜む手がかりの探索
精密医療の実現に向けて医療の進歩を支えるイルミナ社員の取り組み
精密医療の実現に向けて医療の進歩を支えるイルミナ社員の取り組み
複雑な卵巣症例における悪性・良性腫瘍の鑑別を支えるマルチオミクス
複雑な卵巣症例における悪性・良性腫瘍の鑑別を支えるマルチオミクス